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 No statistical difference was observed according to secondary patency rates.
 Postoperative complication rate was 9.6%.
 Operating surgeon is not a major factor on radiocephalic fistula patency rates.a r t i c l e i n f o
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Introduction: Hemodialysis with arteriovenous fistula (AVF) has been widely accepted treatment mo-
dality for patients with chronic renal failure (CRF). Radiocephalic fistulas are considered to be the most
desirable for the initial vascular access. The aim of this study is to investigate the surgeon factor on
radiocephalic fistula patency rates.
Methods: A total of 186 patients with diagnosis of CRF underwent Radiocephalic fistula for hemodialysis
access were included. Patients were divided into 2 groups according to operating surgeon. Patients were
evaluated according to demographic characteristics, secondary patency rates, second AVF creation and
complications.
Results: Mean age was 57.7 ± 14.8 years. The most common etiology of CRF was idiopathic (66.6%). 40
(75.5%) patients in group 1 and 122 (91.7%) patients in group 2 were pre-dialysis patients (p < 0.05).
Overall secondary patency rate was 77.4%. Patients in group 1 and group 2 have secondary patency rates
of 83% and 75.2%, respectively (p ¼ 0.458). Second AVF creation was done in 2 (3.8%) patients in group 1
and 23 (17.3%) patients in group 2 (p < 0.05). Postoperative complication rate was 9.6%.
Conclusion: Operating surgeon is not a major factor of secondary patency in radiocephalic arteriovenous
fistulas.
© 2015 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Renal replacement therapy (RRT) is the only treatment modality
except renal transplantation for chronic renal failure (CRF) that can
be achieved with either hemodialysis or peritoneal dialysis. AVFs
are preferred due to longer patency, decreased thrombosis, infec-
tion, and mortality rates compared to arteriovenous grafts (AVG)
and central venous catheters [1]. Proximal or distal AVFs have
different patency rates however distal AVFs on non-dominant siteeaching and Research Center,
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radiocephalic fistula, described in 1966, is the distal AVF considered
to be the most desirable for the initial vascular access [2]. This
fistula is accepted as to be the gold standard for vascular access in
CRF patients [3]. Primary failure rates has been reported to be
15e30% [4,5]. As the diameter of artery and vein increases from
distal to proximal arm, patency rates also increase. Patency rates
can also be influenced by operating surgeon factor especially for
distal AVFs that need high technical skill and experience. The aim of
the current study is to investigate the surgeon factor on distal AVF,
radiocephalic fistula, patency rates.2. Methods
A total of 408 consecutive patients with diagnosis of CRFoup Limited. This is an open access article under the CC BY-NC-ND license (http://
 from ClinicalKey.com by Elsevier on September 18, 2019.
n. Copyright ©2019. Elsevier Inc. All rights reserved.
Table 1
Characteristics of the patients in both groups.
EVAS (n ¼ 53) OS (n ¼ 133) P value
Male/Female 42/11 75/58 0.004
Age (years)a 61 ± 16 56.4 ± 14.2 0.027
CRF duration (Months)a 19 ± 36.9 16 ± 27.8 0.927
BMI (kg/cm2)a 24.4 ± 4.1 24.5 ± 2.8 0.507
Preemptive renal disease (%) 75.5 91.7 0.005
AVF site (%) 1.000
Right 20.8 20.3
Left 79.2 79.7
Anastomosis type (%) 0.000
Side-to-side 0 63.2
End-to-side 100 36.8
Operation time (Minutes)a 30.6 ± 12.4 58.2 ± 23 0.000
Abbreviations: AVF: Arteriovenous fistula, BMI: Body mass index, CRF: Chronic
renal failure, EVAS: Experienced vascular access surgeon, OS: Other surgeons.
a Values are means ± standard deviation.
I.M. Arer, H. Yabanoglu / Annals of Medicine and Surgery 5 (2016) 86e89 87underwent arteriovenous fistula for hemodialysis access between
October 2011 and February 2015 in Baskent University Adana
Teaching and Research Center. Of these patients 186 underwent
radiocephalic fistula creationwere included in our study. Snuff-box
and proximal radiocephalic fistulas were excluded. Data were
collected retrospectively and randomizationwas not done. Patients
were divided into 2 groups according to performing surgeon; group
1 consists of one general surgeon experienced on vascular access
surgery (approximately performing 160e200 vascular access op-
erations per year) and group 2 consists of other eight surgeons
which are residents performing all general surgery operations
(averagely performing 30e50 vascular access operations per year).
All patients were operated under local anesthesia. All patients were
evaluated for age, sex, comorbidity, etiology, duration of CRF,
number of previous AVFs, arterial, venous, and anastomosis diam-
eter, AVF site, anastomosis technique, preoperative mapping with
venography, postoperative intravenous heparin infusion, post-
operative secondary intervention (for bleeding, thrombus etc.),
presence of early-term complications such as hematoma, bleeding,
infection and thrombosis affecting patency, presence of angio-
graphic or surgical intervention for complications, catheterization
during operation, operation time, secondary patency rates, func-
tionality of vascular excess (presence of thrill or murmur), preop-
erative presence of central catheter and second AVF creation.
Preoperative venous mapping with venography was carried out
when there is a history of multiple AVF operations or there was a
problem related to venous structures on physical examination.
Patients with insufficient thrill after anastomosis were adminis-
tered IV heparin infusion at 100 U/kg for 12 h. Enteric-coated
aspirin 100 mg was prescribed on discharge next day after sur-
gery to all patients. The patients were checked at the end of the first
and third weeks. Patients with functioning AVFs underwent he-
modialysis at the end of 4th week.
The distal part of the non-dominant extremity was selected as
the vessel and anatomical site whenever possible. Physical exami-
nation was done for all patients. The criteria of operability without
ancillary tests were i) confirming adequate circulation according to
Allen test; ii) the power of arterial pulsation being of 2 out of 4 in
semi quantitative assessment; iii) vein diameter being at least
1 mm in tourniquet-free evaluation and 2 mm in tourniquet eval-
uation, and returning to its original diameter when tourniquet is
removed; and iv) the suitable vein being observed for at least 5 cm
and easily compressible. Secondary patency was defined as four
consecutive hemodialysis procedure without problem together
with the presence of thrill and/or murmur 1 month after the
operation.
3. Statistical analysis
Statistical analysis was performed using the statistical package
SPSS (Version 17.0, SPSS Inc., Chicago, IL, USA). For each continuous
variable, normality was checked by Kolmogorov Smirnov and
ShapiroeWilk tests and by histograms. Comparisons between
groups were applied using Mann Whitney U test were used for the
data not normally distributed. The categorical variables between
the groupswas analyzed by using the Chi square test or Fisher Exact
test. A multiple logistic regression analysis was used to know as-
sociations between group and other measurements, with group as
dependent variable. Values of p < 0.05were considered statistically.
4. Results
Among 186 patients 53 (29%) were in group 1whereas 133 (71%)
were in group 2. Characteristics of patients were given in Table 1.
117 (62.9%) patients were male and 69 (37.1%) female. Mean age ofDownloaded for Anonymous User (n/a) at Baskent University fro
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respectively that is statistically different (p ¼ 0.027). The most
common etiology of CRF was idiopathic (66.6%), followed by dia-
betes (19.4%), hypertension (4.8%), glomerulonephritis (3.8%), stone
disease (2.7%), polycystic kidney disease (2.2%) and Alport syn-
drome (0.5%). Hypertension (31.7%) was the most common co-
morbidity followed by coronary artery disease together with
hypertension and diabetes (20.4%), hypertension and diabetes
together (17.2%), diabetes (8.6%), congestive heart failure (2.7%).
The mean CRF duration was 19 ± 36.9 months for group 1 and
16 ± 27.8 months for group 2 (p ¼ 0.927). Average body mass index
(BMI) for group 1 was 24.4 ± 4.1 for group 1 and 24.5 ± 2.8 kg/cm2
(p ¼ 0.507). Most of the patients were predialysis therefore 40
(75.5%) patients in group 1 and 122 (91.7%) patients in group 2 did
not have prior AVF surgery. 12 (6.5%) patients have 2 prior AVF
operations, 9 (4.8%) patients have 1 AVF operation and 3 (1.6%)
patients have 3 AVF operations. The most common site of AVF was
left (79.6%) being the non-dominant site whereas right site was
preferred in 38 (20.4%) patients. There was no statistical difference
between groups according to site (p > 0.05). Preoperative vascular
mapping with digital subtraction venography was performed in
only 33 (17.7%) patients. Surgeon of group 1 performed only end to
side anastomosis whereas surgeons in group 2 performed side-to-
side anastomosis in 84 (63.2%) and end-to-side anastomosis in 49
(36.8%) patients. Mean operation time of patients for group 1 and 2
was 30.6 ± 12.4 and 58.2 ± 23min respectively (p¼ 0.000). Average
artery, vein and anastomosis diameters for group 1 were
2.45 ± 0.59 and 2.35 ± 0.64 and 3.04 ± 0.79 mm respectively
whereas group 2 measurements were 3.32 ± 0.56 and 3.21 ± 0.61
and 5 ± 1.86 mm respectively (Table 2). Significant statistical dif-
ference between groups was observed according to artery, vein and
anastomosis diameters (p ¼ 0.000). Intraoperative catheter
administration was done in 1 (1.9%) patient of group 1 and 21
(15.8%) patients of group 2 that is statistically significant
(p¼ 0.005).15 (28.3%) patients in group 1 and 44 (33.1%) patients in
group 2 received postoperative heparin infusion for 24 h (p > 0.05).
Of 123 patients have central venous catheter, 37 (69.8%) were in
group 1 and 86 (64.7%) were in group 2 (p ¼ 0.607). Overall sec-
ondary patency rate was 77.4%. Patients in group 1 and group 2
have primary patency rates of 83% and 75.2%, respectively
(p ¼ 0.458). Early postoperative complications such as venous
thrombosis, bleeding and seroma were observed in 6 (11.3%) pa-
tients of group 1 and 12 (9%) patients of group 2 (p¼ 0.252). Second
AVF creationwas done in 2 (3.8%) patients in group 1 and 23 (17.3%)
patients in group 2 that is statistically significant (p ¼ 0.016). No
postoperative mortality was observed but overall mortality was
seen in 15 patients (8.1%).m ClinicalKey.com by Elsevier on September 18, 2019.
opyright ©2019. Elsevier Inc. All rights reserved.
Table 2
Intraoperative data and patency rates of both groups.
EVAS (n ¼ 53) OS (n ¼ 133) P value
Artery diameter (mm)a 2.45 ± 0.59 3.32 ± 0.56 0.000
Vein diameter (mm)a 2.35 ± 0.64 3.21 ± 0.61 0.000
Anastomosis diameter (mm)a 3.04 ± 0.79 5 ± 1.86 0.000
ICA (%) 1.9 15.8 0.005
Presence of central catheter (%) 69.8 64.7 0.607
Secondary patency (%) 83 75.2 0.458
Second AVF creation (%) 3.8 17.3 0.016
Abbreviations: AVF: Arteriovenous fistula, EVS: Experienced vascular access sur-
geon, ICA: Intraoperative catheter administration, OS: Other surgeons.
a Values are means ± standard deviation.
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patency rates in multiple logistic regression analysis clustered at
experienced vascular surgeon and other surgeons. The odds ratio of
secondary patency rate of experienced vascular surgeon as the ar-
tery diameter decreases was six times more than other surgeons
[odds ratio (OR) 6.498, 95% confidence interval (95% CI) 1.820 to
23.198, P ¼ 0.004]. The odds ratio of secondary patency rate of
experienced vascular surgeon as the vein diameter decreases was
three times more than other surgeons [odds ratio (OR) 3.643, 95%
confidence interval (95% CI) 1.163 to 11.410, P ¼ 0.026]. These
findings suggest that experienced vascular surgeon has better
secondary patency rates compared to other surgeons as the artery
or vein diameter decreases. No statistically significant difference
was observed in other parameters.5. Discussion
National Kidney Foundation Department Outcomes Quality
Initiative guidelines state that AVF is the optimum method for
dialysis access [6]. AVF site should be selected as the non-dominant
site for achieving comfort of the patient. Primary vascular access
should be started from the distal arm such as radiocephalic fistula.
However the primary AVF failure rates were higher (28% for distal,
20% for proximal arm, P ¼ 0.001) in more distal compared with
proximal arm [7]. Although risk factors for AVF failure such as older
age, female gender, presence of diabetes and distal AVFs have been
identified [8], another factor, operating surgeon factor should have
to be investigated. Several studies investigated surgeon factor and
stated that vascular access for hemodialysis should be performed
by either an experienced vascular surgeon or under his supervision
[9,10]. However some studies did not find statistical difference
regarding surgeon factor, they encourage surgical trainees to be
specialized in this field without causing impairment in patient care
[11,12]. This factor was first evaluated in literature by the study of
Prischl et al. and found its prognostic relevance in short and long-
term AVF patency rates [13]. In this current study although we
can not find significant difference between groups, we also advo-
cate AVF operations have to be performed by experienced vascularTable 3
Logistic regression model for odds of surgeon factor.
Odds ratio (95% CI) P value
Age 0.970 (0.934e1.007) 0.108
Sex 2.257 (0.736e6.923) 0.154
Artery diameter 6.498 (1.820e23.198) 0.004
Vein diameter 3.643 (1.163e11.410) 0.026
Anastomosis diameter 0.759 (0.275e2.094) 0.595
ICA 0.485 (0.000e798.428) 0.848
Second AVF creation 4.667 (0.676e32.201) 0.118
Abbreviations: ICA: Intraoperative catheter administration.
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Distal AVFs are recommended for initial hemodialysis access
[14]. The most common of distal AVFs, Brescia-Cimino fistula, was
first described as side-to-side anastomosis however in a recent
review end-to-side anastomosis technique is recommended in
distal AVFs [15]. In our study experienced vascular access surgeon
preferred end-to-side anastomosis in all operations although other
surgeons performed this type of anastomosis in only 36.8% of pa-
tients. This makes one of the limitations of our study as the sec-
ondary patency rates may have been disturbed by difference in
anastomosis technique. As end-to-side anastomosis needs more
skill and experience to be accurately performed, application of this
technique by surgeons have lower experience in vascular access
may also influence patency rates. Retrospective design of this study
is another limitation.
Artery, vein and anastomosis diameter can also affect patency
rates. Since vessel diameter 2 mm in distal arm is not recom-
mended [16,17], average artery and vein diameters for experienced
surgeon group are 2.45 ± 0.59 and 2.35 ± 0.64 mm in the current
study that is significantly different with other surgeons. This may
be due to experienced surgeon preformed AVF creation in patients
with non-visible vein on physical examination whereas others
preferred preoperative imaging or patients with visible vein on
physical examination. As other surgeons preferred usually side-to-
side anastomosis, higher anastomosis diameters are observed.
Patients with CRF have higher cardiovascular disease compli-
cations, including atherosclerosis [18]. The generation of advanced
glycation end products is increased in patients with CRF, which
contributes to vascular injury [19]. As the duration of CRF increases,
vascular injury also increases. Patients with preemptive disease
have less vascular injury than the patinets that have long duration
of CRF. In the current study, 91.7% of patients in other surgeons
group were predialysis whereas only 75.5% of patients in experi-
enced vascular access surgeon group were predialysis, which may
contribute to patency rates not being statistically different.
Primary patency rates for distal AVFs is reported to be as high as
96.8% unfortunately secondary patency rates are decreased to
75.6% [20]. Fassiadis et al. [10] found primary and secondary
patency rates as 80% vs. 93% in consultant surgeon group and 74%
vs. 81% in junior surgeons group (p < 0.025). Overall secondary
patency rates were 77.4% and secondary patency rates of experi-
enced surgeon group (83%) and other surgeons group (75.2%) in the
current study is similar with the literature findings however not
significantly different (p > 0.05). However statistical difference
between groups was observed for second AVF creation and expe-
rienced vascular access surgeon performed second AVF surgery in
only 3.8% patients (p < 0.05).
6. Conclusion
Formation of distal AVFs is a challenging issue with difficult
technical skills. Although experienced vascular access surgeon has
better secondary patency rates, statistical difference with other
surgeons is not observed. Thus in order to understand accurate
effect of surgeon factor, prospective randomized studies should be
performed.
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